期刊文献+

SUMO化修饰与血液系统疾病 被引量:3

Sumoylation and Its Role in Hematological Disease
下载PDF
导出
摘要 小泛素相关修饰物(SUMO)修饰为继泛素化修饰后又一种主要的蛋白翻译后修饰,参与调控多种细胞生命活动,如蛋白质间相互作用、胞内定位、DNA修复、转录因子的活化,以及细胞周期和转录的调控等,并与多种疾病的发病密切相关。近年来的研究表明,SUMO化修饰也参与了多种血液系统疾病的发病。本文综述了SUMO化修饰对血液系统疾病发病及治疗的影响。 Small ubiquitin-related modifier(SUMO) can be covalently attached to target proteins and thereby plays a crucial role in regulating the normal functions of cells, such as protein-protein interaction, subcellu]ar localization, DNA repair, cell cycle and transcription factor regulation. Several lines have imp^cated that sumoylation is important in disease occurrence and development. This brief review will focus on some recent findings about the roles of sumoylation in the etiology and treatment of hematological malignancies.
作者 黄禾菁 侯健
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2013年第1期218-221,共4页 Journal of Experimental Hematology
基金 青年科学基金项目(编号81001015)
关键词 小泛素相关修饰物 SUMO化修饰 血液系统疾病 small ubiguitin-related modifier sumoylation hematological malignancy
  • 相关文献

参考文献43

  • 1Kim KI, Back SH, Jeon YJ, et al. A new SUMO-l-specific protease, SUSP1, that is highly expressed in reproductive organs. J Biol Chem, 2000 ; 275 (19) : 14102 - 14106.
  • 2Tatham MH, Jaffray E, Vaughan OA, et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem, 2001 ; 276 ( 38 ) : 35368 - 35374.
  • 3Gelss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol, 2007; 8(12) : 947 -956.
  • 4Strutt D. Frizzled signalling and cell polarisation in Drosophila and vertebrates. Development, 2003 ; 130(19) : 4501 -4513.
  • 5Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sei, 2007 ; 32 (6) : 286 - 295.
  • 6Johnson ES, Gupta AA. An E3-1ike factor that promotes SUMO conjugation to the yeast septins. Cell, 2001; 106(6) : 735 -744.
  • 7Kagey MH, Melhuish TA, Wotton D. The potycomb protein Pc2 is a SUMO E3. Cell, 2003; 113(1) : 127 -137.
  • 8Kahyo T, Nishida T, Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell ,2001 ;8 ( 3 ) :713 - 718.
  • 9Pichler A, Gast A, Seeler JS, et al. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell, 2002 ; 108 ( 1 ) : 109 - 120.
  • 10Takahashi Y, Kahyo T, Toh EA, et al. Yeast Ulll/Sizl is a novel SUMO1/Smt3 ligase for septin components and functions as an adaptor between conjugating enzyme and substrates. J Biol Chem, 2001; 276(52): 48973-48977.

同被引文献48

  • 1倪晓光,赵平.泛素-蛋白酶体途径与恶性肿瘤关系的研究进展[J].中华肿瘤防治杂志,2007,14(19):1512-1515. 被引量:20
  • 2HAY R T.SUMO:a history of modification[J].Mol Cell,2005,18:1-12.
  • 3GEISS-FRIEDLANDER R,MELCHIOR F.Concepts in sumoylation:a decade on[J].Nat Rev Mol Cell Biol,2007,8:947-956.
  • 4GUO D,LI M,ZHANG Y,et al.A functional variant of SUMO4,a new I kappa B alpha modifier,is associated with type 1diabetes[J].Nat Genet,2004,36:837-841.
  • 5BOHREN K M,NADKARNI V,SONG J H,et al.A M55Vpolymorphism in a novel SUMO gene(SUMO-4)differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus[J].J Biol Chem,2004,279:27233-27238.
  • 6HECKER C M,RABILLER M,HAGLUND K,et al.Specification of SUMO1-and SUMO2-interacting motifs[J].J Biol Chem,2006,281:16117-16127.
  • 7SAITOH H,HINCHEY J.Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1versus SUMO-2/3[J].J Biol Chem,2000,275:6252-6258.
  • 8LOMELH,VZQUEZ M.Emerging roles of the SUMO pathway in development[J].Cell Mol Life Sci,2011,68:4045-4064.
  • 9RODRIGUEZ M S,DARGEMONT C,HAY R T.SUMO-1conjugation in vivo requires both a consensus modification motif and nuclear targeting[J].J Biol Chem,2001,276:12654-12659.
  • 10YEH E T.SUMOylation and De-SUMOylation:wrestling with life's processes[J].J Biol Chem,2009,284:8223-8227.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部